All subjects
Biochemicals & Materials

Green Biologics achieves EU REACH certification for bio-based n-butanol

Green Biologics, Inc., has announced that it has received European Union (EU) Registration, Evaluation, Authorisation of Chemicals (REACH) certification for its bio-based n-butanol from its recently opened US facility in Little Falls, Minnesota (MN).

The Central Minnesota Renewables plant in Little Falls, MN (photo courtesy Green Biologics). The Central Minnesota Renewables plant in Little Falls, MN (photo courtesy Green Biologics).

Green Biologics, Inc., the US subsidiary of Green Biologics Ltd, a UK industrial biotechnology and renewable chemicals company, has announced that it has received Registration, Evaluation, Authorisation of Chemicals (REACH) certification, a regulation of the European Union (EU) that promotes protection of human and environmental health from risks posed by chemicals.

By registering with REACH, Green Biologics is now able to supply Europe with larger bulk quantities of its bio-based n-butanol. The company has also obtained pre-registration for its bio-based acetone and various derivatives, allowing it to ship up to 100 tonnes of these chemicals to Europe through June 1, 2018. The company’s n-butanol and acetone have received 100 percent bio-based, USDA BioPreferred certification.

According to the company, this achievement underlines its commitment to “embracing a global view” on customers and business and enables the company to solidify its long-term position as a supplier to customers and markets in Europe.

Although Green Biologics’ first manufacturing site is based in North America, as the only producer of bio-based n-butanol and acetone in the world there is a wide range of opportunities for our products to be adopted across Europe as replacements to their traditional petroleum-based counterparts. Europe will be a key growth market for our company and the REACH registration of our n-butanol will help us navigate the many complex regulatory requirements associated with importing chemicals into the region, said Sean Sutcliffe, Chief Executive at Green Biologics in a statement.

Green Biologics’ fermentation platform utilises a “library” of Clostridium microbial strains as biocatalysts to produce its 100 percent biobased n-butanol and acetone. The company has plans to offer a full “BioPure” suite, 100 percent biobased, high purity, products through its patented Advanced Fermentation Process (AFP) and third-party partnerships.

Currently, all Green Biologics chemical products are being produced at the company’s commercial facility, Central Minnesota Renewables, located in Little Falls, MN, which officially began operations in December 2016.

The Little Falls plant was purchased in December 2014 through the acquisition of assets from the Central MN Ethanol Cooperative LLC (CMEC). Green Biologics re-named the site Central MN Renewables (CMR) and commenced construction on its renewable chemicals facility in September 2015.

The 21 million US gallon (≈ 79.5 million litre) per annum capacity ethanol plant was retrofitted with Green Biologics’proprietary AFP to produce bio-based n-butanol and acetone.

Most read on Bioenergy International

Get the latest news about Bioenergy

Subscribe for free to our newsletter
Sending request
I accept that Bioenergy International stores and handles my information.
Read more about our integritypolicy here